Physician

Shilpa Oberoi, MD

According to 2025 Medicare claims, Shilpa Oberoi, MD (NPI: 1285893487) practices internal medicine in the Ocala, FL market, with the plurality of this provider's patient population coming from Marion, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 34474-9673.

Oberoi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,554 traditional Medicare patients, billed 329,408 HCPCS/CPT codes, and received $4,720,619 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,888 prescription claims across 443 beneficiaries totaling $6,133,021 in drug costs, led by Revlimid (Lenalidomide). 2020 DME data shows 11 claims. Open Payments data shows 127 records totaling $2,516. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $530,961 to $4,720,619. Similarly, Part D prescription costs have moved sharply higher in recent years, from $257,217 to $6,133,021. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.